| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
76,182,000 |
| Market
Cap: |
13.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$127.77 - $330.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 882 |
| Guru Rank Value : 0.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH™ Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,551 |
8,851 |
| Total Buy Value |
$0 |
$0 |
$1,006,995 |
$2,012,670 |
| Total People Bought |
0 |
0 |
2 |
3 |
| Total Buy Transactions |
0 |
0 |
2 |
3 |
| Total Shares Sold |
3,300 |
14,981 |
52,044 |
170,562 |
| Total Sell Value |
$596,970 |
$2,503,218 |
$8,850,279 |
$40,925,357 |
| Total People Sold |
1 |
3 |
5 |
8 |
| Total Sell Transactions |
1 |
3 |
8 |
21 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Alpuche Charles |
EVP, Global Manufacturing |
• • – |
2017-09-06 |
4 |
B |
$58.08 |
$145,212 |
D/D |
2,500 |
34,709 |
2.74 |
- |
|
| Minogue Michael R |
Director |
• • – |
2017-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,173 |
3,173 |
|
- |
|
| Mullen James C |
Director |
• • – |
2017-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,098 |
3,098 |
|
- |
|
| Spears Michael P |
SVP, QA and RA |
• • – |
2017-07-27 |
4 |
D |
$52.26 |
$127,201 |
D/D |
(2,434) |
35,621 |
|
- |
|
| Christensen Bret |
SVP and CCO |
• • – |
2017-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,006 |
7,006 |
|
- |
|
| Zakrzewski Joseph S |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
30,558 |
|
- |
|
| Sommer Regina O |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
23,039 |
|
- |
|
| Lemoine David A |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
10,123 |
|
- |
|
| Hopfield Jessica |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
17,937 |
|
- |
|
| Scannell Timothy J |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
18,639 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
18,558 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,709 |
24,558 |
|
- |
|
| Spears Michael P |
SVP, QA and RA |
• • – |
2017-05-16 |
4 |
B |
$40.59 |
$101,470 |
D/D |
2,500 |
38,055 |
2.74 |
- |
|
| Thomas Bradley A |
EVP Human Resources |
• • – |
2017-05-11 |
4 |
B |
$38.69 |
$116,077 |
D/D |
3,000 |
63,778 |
2.74 |
- |
|
| Hopfield Jessica |
Director |
• • – |
2017-05-11 |
4 |
B |
$38.68 |
$99,783 |
D/D |
2,580 |
15,228 |
2.39 |
- |
|
| Lemoine David A |
Director |
• • – |
2017-05-01 |
4 |
AS |
$43.40 |
$66,142 |
D/D |
(1,524) |
7,414 |
|
- |
|
| Petrovic Shacey |
President and COO |
• • – |
2017-04-01 |
4 |
D |
$43.09 |
$46,149 |
D/D |
(1,071) |
82,922 |
|
- |
|
| Abdel-Malek Aiman |
SVP, Advanced Technology |
• • – |
2017-03-28 |
4 |
D |
$42.43 |
$64,578 |
D/D |
(1,522) |
16,353 |
|
- |
|
| Lemoine David A |
Director |
• • – |
2017-03-06 |
4 |
AS |
$45.15 |
$57,882 |
D/D |
(1,282) |
8,938 |
|
- |
|
| Zakrzewski Joseph S |
Director |
• • – |
2017-03-02 |
4 |
S |
$46.31 |
$1,874,495 |
D/D |
(40,000) |
27,849 |
|
- |
|
| Zakrzewski Joseph S |
Director |
• • – |
2017-03-02 |
4 |
OE |
$7.06 |
$521,489 |
D/D |
40,000 |
67,849 |
|
- |
|
| Petrovic Shacey |
President and COO |
• • – |
2017-02-24 |
4 |
D |
$45.96 |
$125,563 |
D/D |
(2,732) |
83,993 |
|
- |
|
| Spears Michael P |
SVP, QA and RA |
• • – |
2017-02-24 |
4 |
D |
$45.96 |
$54,509 |
D/D |
(1,186) |
35,555 |
|
- |
|
| Alpuche Charles |
EVP, Global Manufacturing |
• • – |
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,818 |
31,596 |
|
- |
|
| Abdel-Malek Aiman |
SVP, Advanced Technology |
• • – |
2017-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,327 |
17,875 |
|
- |
|
683 Records found
|
|
Page 22 of 28 |
|
|
3.15 (1.85%) 
